Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
33 Cards in this Set
- Front
- Back
Bactericidal inhibitors
|
1. Aminoglycosides
2. Streptogramins |
|
Aminoglycosides (Names)
|
1. Gentamicin
2. Amikacin 3. Tobramycin 4. Streptomycin |
|
Streptogramins (Names)
|
1. Dalfopristin
2. Quinupristin |
|
Aminoglycosides:
Administration & Distribution |
Parenteral administration
Poor GI absorption No CSF distribution Concentration-dependent killing Long post-antibiotic effect |
|
Aminoglycosides:
Elimination |
Renal excretion
Unchanged form |
|
Aminoglycosides:
Toxic effects |
Ototoxicty; nephrotoxicity; neuromuscular blockade (possible)
|
|
Aminoglycosides:
Mechanism of action |
Oxygen dependent uptake across cytoplasmic membrane (only aerobes affected)
Binds to 30S subunit & breaks down initiation complex |
|
Aminoglycosides:
Antimicrobial activity |
Gram-negative aerobes
Combined w/ B lactam for gram-positive bacilli (synergistic relationship) |
|
Aminoglycosides:
Resistance mechanisms |
1) Enzymes which phosphorylate, adenylate or acetylate
2) Decreased uptake 3) Alteration of 30S binding site |
|
Spectinomycin:
Administration |
Parenteral (IM)
|
|
Spectinomycin:
Elimination |
Excreted by kidneys in original form
|
|
Spectinomycin:
Toxicity |
Nausea, chills, fever, dizziness, rashes
|
|
Spectinomycin:
Mechanism of action |
Bacteriostatic;
Binds to 30S & 70S subunits to bind translocation step of synthesis |
|
Spectinomycin:
Antimicrobial activity |
Alternative to penicillin-allergic patients for treatment of fluoroquinolone-resistant Neisseria gonorrhoeae
|
|
Bacteriostatic inhibitors
|
1. Spectinomycin
2. Chloramphenicol 3. Tetracyclines 4. Erythromycin 5. Clindamycin 6. Linezolid (Oxazolidinones) |
|
Chloramphenicol:
Administration & distribution |
Absorbed from the GI tract & enters CNS
|
|
Chloramphenicol:
Elimination |
Inactivated in liver by glucuronyl transferase
|
|
Chloramphenicol:
Toxic effects |
Aplastic anemia rare but fatal
Dose-related bone marrow toxicity Gray-baby syndrome Inhibits P450 metabolism |
|
Chloramphenicol:
Mechanism of action |
Bacteriostatic
Binds to 50S subunit of 70S ribosome & inhibits peptidyl transferase |
|
Chloramphenicol:
Mechanism of resistance |
Enzyme, chloramphenicol acetyl transferase (CAT) acetylates & inactivates the drug.
Plasmid-mediated |
|
Tetracyclines (Names)
|
1. Doxycycline
2. Minocycline Bacteriostatic |
|
Tetracyclines:
Administration and distribution |
PO or IV
Impaired by milk, cations, iron preparations b/c of chelation of these ions by the drug & poor absorption No entry into CNS |
|
Tetracyclines:
Elimination |
Removed by liver & enters enterohepatic circulation
Eliminated by feces & urine |
|
Tetracyclines:
Toxic effects |
GI irritation
Photosensitivity (doxycycline) Hepatotoxicity w/ overdosing Bone deposition (discoloration) Outdated cause Fanconi syndrome Potentially nephrotoxic if renal insufficiency |
|
Tetracyclines:
Mechanism of action |
Bacteriostatic
Bind to 30S subunit of 70S ribosome & inhibit binding of amino acyl-tRNA |
|
Tetracyclines:
Antimicrobial activity |
Mycoplasma pneumoniae, rickettsial infections, Chlamydiae, Vibrio cholera, Brucella, Borrelia
|
|
Tetracyclines:
Mechanisms of resistance |
1) Increased efflux by active transport pump
2) Ribosome protection from proteins which interfere with binding |
|
Clindamycin:
Administration and distribution |
PO or parenteral
No CSF entry |
|
Clindamycin:
Elimination |
10% excreted in kidney
Metabolized in liver & excreted in bile Long excretion time (2 weeks) |
|
Clindamycin:
Toxic effects |
Severe diarrhea (pseudomembranous colitis) due to C. difficile
Hepatotoxicity |
|
Clindamycin:
Mechanism of action |
Bacteriostatic
Binds 50S subunit of 70S ribosome & blocks the binding of the aminoacyl-tRNA substrate to the A site on the ribosome |
|
Clindamycin:
Antimicrobial activity |
Moderate to severe anaerobic infections
|
|
Clindamycin:
Mechanism of resistance |
1) Mutation of the ribosomal binding site
2) Production of methylase 3) Inactivation of the drug |